Now that the Trump administration has abandoned its bid to overhaul the Medicare Part D drug rebate system (RDB 7/11/19, p. 8), all eyes are on what Congress will do to address the ever-vexing problem of high drug prices.
- People on the Move
- Medicare and Medicaid
- Datapoint, Drug Benefits
- Headlines in the News
- Abstract, Medicare and Medicaid